Literature DB >> 1370685

cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression.

G Garnier1, B Ault, M Kramer, H R Colten.   

Abstract

Factor B (Bf), an enzyme of the alternative pathway of complement activation, is one of four major histocompatibility complex (MHC) class III genes. To ascertain the genetic mechanism for tissue-specific constitutive and regulated expression of Bf, we sequenced the regulatory regions 5' of the gene from mice of different H-2 MHC haplotypes and assessed trans-acting factors, specific DNA binding nucleoproteins, in liver and kidney. Striking tissue-specific differences in constitutive expression of Bf were demonstrated in mice of H-2f or H-2z haplotypes when compared with H-2d or H-2u (kidney and intestinal Bf in H-2d or H-2u much greater than H-2f or H-2z). These differences correlated with a point nucleotide substitution 3 bp downstream of the upstream Bf initiation site that affects interaction with a DNA binding protein. This and additional cis differences localize the sequence substitutions responsible for previously identified restriction fragment length polymorphisms among inbred mouse strains and also reveal two previously unrecognized polymorphisms generated by SmaI and HinfI digestion. Evidence for differences in trans was found in a comparison of DNA binding nucleoproteins from kidney, but not liver, of B10.PL when compared with B10.M. These data, together with the high degree of sequence homology between human and mouse Bf 5' flanking regions, should prompt a search for polymorphic restriction sites and cis binding elements in the Bf promoter that could serve as markers of human MHC-associated renal pathology and variants in local MHC class III gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370685      PMCID: PMC2119128          DOI: 10.1084/jem.175.2.471

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

2.  GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase.

Authors:  S P Jackson; J J MacDonald; S Lees-Miller; R Tjian
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  Use of a protein-blotting procedure and a specific DNA probe to identify nuclear proteins that recognize the promoter region of the transferrin receptor gene.

Authors:  W K Miskimins; M P Roberts; A McClelland; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.

Authors:  J H Passwell; G F Schreiner; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

7.  Regulation of human and murine complement: comparison of 5' structural and functional elements regulating human and murine complement factor B gene expression.

Authors:  M Nonaka; J D Gitlin; H R Colten
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

8.  Tissue-specific initiation of murine complement factor B mRNA transcription.

Authors:  M Nonaka; N Ishikawa; J Passwell; S Natsuume-Sakai; H R Colten
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

9.  Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.

Authors:  R A Wetsel; D T Fleischer; D L Haviland
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

10.  The induction of macrophage spreading by factor B of the properdin system.

Authors:  O Götze; C Bianco; Z A Cohn
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  4 in total

1.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Abrogation of the alternative complement pathway by targeted deletion of murine factor B.

Authors:  M Matsumoto; W Fukuda; A Circolo; J Goellner; J Strauss-Schoenberger; X Wang; S Fujita; T Hidvegi; D D Chaplin; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.

Authors:  Aditi Gupta; Garima Juyal; Ajit Sood; Vandana Midha; Keiko Yamazaki; Arnau Vich Vila; Motohiro Esaki; Toshiyuki Matsui; Atsushi Takahashi; Michiaki Kubo; Rinse K Weersma; B K Thelma
Journal:  Eur J Hum Genet       Date:  2016-10-19       Impact factor: 4.246

4.  Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.

Authors:  Peter N Lalli; Michael G Strainic; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.